![](/img/cover-not-exists.png)
S1019 A Randomized Phase II Study Designed to Compare Toxicity and Dose Intensity Between Four-Week Versus Three-Week Schedule of Gemcitabine for Advanced Pancreatic Cancer
Ken Hirao, Hirofumi Kawamoto, Kazuhide Yamamoto, Ichiro Sakakibara, Naoki Yamamoto, Sigeru Horiguchi, Koichiro Tsutsumi, Masakuni Fujii, Hironari Kato, Naoko KuriharaVolume:
138
Year:
2010
Language:
english
DOI:
10.1016/s0016-5085(10)60741-x
File:
PDF, 143 KB
english, 2010